Exudative Age-related Macular Degeneration Clinical Trials

43 clinical trials for Exudative Age-related Macular Degeneration across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration — RECRUITING
• Ethical Issues of Using Gene Therapy in the Treatment of AMD — RECRUITING
• Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-group, active-control, observer-masked, superiority, randomised controlled surgical trial. — RECRUITING · PHASE3
• Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration — RECRUITING
• Dose-Escalation Study of AL-39324 Suspension versus Lucentis for the Treatment of Exudative AMD — COMPLETED · PHASE2
• Home Monitoring in eAMD Treatment — NOT_YET_RECRUITING
• Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy — WITHDRAWN · PHASE4
• A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration — COMPLETED · PHASE2
• A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration — COMPLETED · PHASE2
• Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD — OTHER · PHASE2
• Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept — COMPLETED · PHASE4
• X-82 to Treat Age-related Macular Degeneration — TERMINATED · PHASE2
• Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph — COMPLETED
• Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF — COMPLETED · PHASE2
• Stem Cell Therapy for Outer Retinal Degenerations — COMPLETED · PHASE1
• Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab — COMPLETED
• Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy — OTHER · PHASE4
• Intravitreal Aflibercept for Submacular Hemorrhage — COMPLETED · PHASE4
• Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD — COMPLETED
• ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) — COMPLETED · PHASE1
• LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration — COMPLETED · PHASE2
• Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD — COMPLETED · PHASE2
• Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD — COMPLETED · NA
• Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD — COMPLETED · PHASE2
• Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab — COMPLETED · PHASE4
• Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy — COMPLETED · PHASE4
• Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD) — COMPLETED
• ESBA1008 Microvolume Study — COMPLETED · PHASE2
• Efficacy and Safety Study of ESBA1008 Versus EYLEA® — COMPLETED · PHASE2
• Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 — OTHER · PHASE4
• Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation — COMPLETED · NA
• FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration — COMPLETED · PHASE4
• LUCAS (Lucentis Compared to Avastin Study) — COMPLETED · PHASE4
• Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration — OTHER · NA
• Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion — COMPLETED · PHASE2
• Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration — COMPLETED
• ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients — COMPLETED · PHASE1
• Monocentric Retrospective Observational Study on Patients With Macular Degeneration — OTHER
• Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration — COMPLETED · PHASE2
• A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD — COMPLETED · PHASE1
• Long-term Follow-up of Subfoveal Neovascular AMD — OTHER
• Bevacizumab for Neovascular Age-related Macular Degeneration — COMPLETED · NA
• The Spectralis-Cirrus Study — COMPLETED

Refine this search